Lyrica 75mg Capsule contains Pregabalin, an anticonvulsant and neuropathic pain agent used primarily for the management of neuropathic pain associated with diabetic peripheral neuropathy, postherpetic neuralgia, and spinal cord injury. It is also indicated as adjunctive therapy for partial onset seizures in adults and for the treatment of generalized anxiety disorder. Pregabalin works by binding to the alpha-2-delta subunit of voltage-gated calcium channels in the central nervous system, thereby modulating calcium influx and reducing the release of excitatory neurotransmitters. This mechanism helps to alleviate pain and seizure activity. Lyrica 75mg is administered orally, with dosage individualized based on patient response and clinical condition. Common side effects may include dizziness, somnolence, dry mouth, edema, blurred vision, weight gain, and difficulty concentrating. Caution is advised in patients with renal impairment, and dose adjustments may be necessary. Lyrica should be used under medical supervision, particularly in patients with a history of substance abuse or mood disorders, due to potential risks of dependence and suicidal ideation. It is contraindicated in patients with known hypersensitivity to pregabalin or any of its excipients. Regular monitoring and adherence to prescribed dosing are essential to optimize therapeutic outcomes and minimize adverse effects.